Science Current Events | Science News | Brightsurf.com
 
Liver Cancer (M.D. Anderson Solid Tumor Oncology Series)
View Larger Image

Liver Cancer (M.D. Anderson Solid Tumor Oncology Series) | Hardcover

by Steven A. Curley (Editor)

List Price: $147.00  
Price:  $135.35
You Save:  $11.65 (8%)
Available:  Usually ships in 24 hours

Binding:  Hardcover
Publisher:  Springer
Edition:  1st Edition
Page Count:  253 Pages
Publication Date:  June 26, 1998
Sales Rank:  2,512,401nd


EDITORIAL REVIEWS


Product Description
Liver Cancer, the inaugural volume in the M.D. Anderson Solid Tumor Oncology series, provides the general surgeon, surgical oncologist, and medical oncologist with the most up-to-date and current standard of multimodality care for hepatobiliary cancer. Surgical approaches, chemotherapy, immunotherapy, gene therapy, and radiotherapy are all presented, giving the practitioner a much needed, comprehensive perspective on all aspects of patient care. The MD Anderson Solid Tumor Oncology series features cutting-edge, in-depth information of vital interest to all practitioners in today's captitated financial milieu. Providers must understand how their component of care interdigitates with the varied medical and surgical teams and apply multimodality approaches to their practice environments.


CUSTOMER REVIEWS (Average Customer Rating: 3.0 based on 1 review)

"If you get Liver Cancer, you are going to die." by Fred Mrozek (German Valley, Illinois United States) 3 Stars
July 30, 2007
When a former co-worker got liver cancer, I bought this book for several reasons, one of which was a search for the best treatments - or, more simply put, for hope. If that is what you are looking for, and nothing else, then skip this book. If, on the other hand, you want essential background to the disease, and can use this background to help negotiate the complex considerations of new chemotherapeutic agents, then this book is recommended. This field is changing rapidly. Not rapidly enough as it turns out, but it seems only a matter of time before a cluster of genetic insights converge and treating such cancers becomes a practical reality. To the researchers doing such work, Godspeed.
© 2009 BrightSurf.com